Reference
Guo J, et al. Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in chinese patients. Chinese Journal of Cancer Research 31: 759-770, No. 5, Oct 2019. Available from: URL: http://doi.org/10.21147/j.issn.1000-9604.2019.05.06
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1791, 35 (2020). https://doi.org/10.1007/s40278-020-74880-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74880-2